CHARLES SCHWAB INVESTMENT MANAGEMENT INC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$1,247,172
-5.7%
14,502
+2.2%
0.00%
Q2 2023$1,322,601
-2.1%
14,191
-0.4%
0.00%
Q1 2023$1,350,757
-4.6%
14,253
+1.2%
0.00%
Q4 2022$1,416,166
+19.2%
14,087
+1.2%
0.00%
Q3 2022$1,188,000
-0.7%
13,9160.0%0.00%
Q2 2022$1,196,000
-10.5%
13,916
-6.4%
0.00%
Q1 2022$1,336,000
-8.2%
14,862
+2.1%
0.00%
Q4 2021$1,456,000
+7.7%
14,5580.0%0.00%
Q3 2021$1,352,000
+9.1%
14,5580.0%0.00%
Q2 2021$1,239,000
-14.6%
14,558
-13.0%
0.00%
-100.0%
Q1 2021$1,450,000
+4.8%
16,740
+2.0%
0.00%0.0%
Q4 2020$1,384,000
+5.5%
16,4170.0%0.00%0.0%
Q3 2020$1,312,000
-11.2%
16,417
-1.5%
0.00%0.0%
Q2 2020$1,478,000
+18.5%
16,668
+25.8%
0.00%0.0%
Q1 2020$1,247,000
+32.5%
13,251
+52.1%
0.00%0.0%
Q4 2019$941,000
+12.7%
8,7120.0%0.00%
Q3 2019$835,000
+0.1%
8,7120.0%0.00%
-100.0%
Q2 2019$834,000
+12.1%
8,712
+3.4%
0.00%
Q1 2019$744,000
+12.9%
8,425
+6.4%
0.00%
-100.0%
Q4 2018$659,000
-9.8%
7,921
+2.2%
0.00%
Q3 2018$731,000
-11.2%
7,751
+3.8%
0.00%
-100.0%
Q2 2018$823,000
+11.5%
7,4650.0%0.00%0.0%
Q1 2018$738,000
+37.9%
7,465
+13.7%
0.00%
Q4 2017$535,000
-5.6%
6,565
-14.7%
0.00%
Q3 2017$567,000
+1.6%
7,7000.0%0.00%
-100.0%
Q2 2017$558,000
-7.6%
7,700
-20.5%
0.00%0.0%
Q1 2017$604,000
-14.4%
9,6910.0%0.00%0.0%
Q4 2016$706,000
+21.7%
9,6910.0%0.00%0.0%
Q3 2016$580,000
-5.1%
9,6910.0%0.00%0.0%
Q2 2016$611,000
+0.7%
9,6910.0%0.00%0.0%
Q1 2016$607,000
+5.7%
9,691
-1.1%
0.00%0.0%
Q4 2015$574,000
+8.7%
9,8000.0%0.00%0.0%
Q3 2015$528,000
-9.7%
9,8000.0%0.00%0.0%
Q2 2015$585,000
+39.3%
9,800
+40.0%
0.00%0.0%
Q1 2015$420,000
-0.2%
7,0000.0%0.00%0.0%
Q4 2014$421,000
+23.1%
7,0000.0%0.00%0.0%
Q3 2014$342,000
-5.3%
7,0000.0%0.00%0.0%
Q2 2014$361,000
-10.9%
7,0000.0%0.00%0.0%
Q1 2014$405,000
+1.0%
7,0000.0%0.00%0.0%
Q4 2013$401,000
-6.1%
7,0000.0%0.00%0.0%
Q3 2013$427,000
+8.9%
7,0000.0%0.00%0.0%
Q2 2013$392,0007,0000.00%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders